ORAL ONCOL 润色咨询

ORAL ONCOLOGY

出版年份：1997 年文章数：2884 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：8.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1187022, encodeId=9de6118e0228d, content=Jan 21 2022 Under Review 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri Jan 21 23:19:00 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083439, encodeId=2a5f1083439a1, content=Dec 22 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Dec 23 07:47:28 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079991, encodeId=88db10e999113, content=Dec 14 with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 16:37:28 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079814, encodeId=a7aa10e98148d, content=偏重的研究方向：头颈肿瘤<br>经验分享：Dec 13 submitted to the journal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 08:39:32 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向： 头颈肿瘤 <br>经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的<span class="quote">风信子苗 2018-12-20 发表::<br>您好，做的什么研究</span><span class="quote">风信子苗 2018-12-20 00:00:00 发表:<br>您好，做的什么研究</span>, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究<span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 <span class="quote">Dr_Hemis_AI 2018-09-10 发表::<br>接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise</span><span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]
    2022-01-21 1465389cm38暂无昵称

    Jan 21 2022 Under Review 变化一次时间

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1187022, encodeId=9de6118e0228d, content=Jan 21 2022 Under Review 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri Jan 21 23:19:00 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083439, encodeId=2a5f1083439a1, content=Dec 22 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Dec 23 07:47:28 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079991, encodeId=88db10e999113, content=Dec 14 with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 16:37:28 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079814, encodeId=a7aa10e98148d, content=偏重的研究方向：头颈肿瘤<br>经验分享：Dec 13 submitted to the journal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 08:39:32 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向： 头颈肿瘤 <br>经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的<span class="quote">风信子苗 2018-12-20 发表::<br>您好，做的什么研究</span><span class="quote">风信子苗 2018-12-20 00:00:00 发表:<br>您好，做的什么研究</span>, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究<span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 <span class="quote">Dr_Hemis_AI 2018-09-10 发表::<br>接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise</span><span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]
    2021-12-23 1465389cm38暂无昵称

    Dec 22 Under Review

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1187022, encodeId=9de6118e0228d, content=Jan 21 2022 Under Review 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri Jan 21 23:19:00 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083439, encodeId=2a5f1083439a1, content=Dec 22 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Dec 23 07:47:28 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079991, encodeId=88db10e999113, content=Dec 14 with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 16:37:28 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079814, encodeId=a7aa10e98148d, content=偏重的研究方向：头颈肿瘤<br>经验分享：Dec 13 submitted to the journal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 08:39:32 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向： 头颈肿瘤 <br>经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的<span class="quote">风信子苗 2018-12-20 发表::<br>您好，做的什么研究</span><span class="quote">风信子苗 2018-12-20 00:00:00 发表:<br>您好，做的什么研究</span>, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究<span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 <span class="quote">Dr_Hemis_AI 2018-09-10 发表::<br>接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise</span><span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]
    2021-12-14 1465389cm38暂无昵称

    Dec 14 with editor

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1187022, encodeId=9de6118e0228d, content=Jan 21 2022 Under Review 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri Jan 21 23:19:00 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083439, encodeId=2a5f1083439a1, content=Dec 22 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Dec 23 07:47:28 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079991, encodeId=88db10e999113, content=Dec 14 with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 16:37:28 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079814, encodeId=a7aa10e98148d, content=偏重的研究方向：头颈肿瘤<br>经验分享：Dec 13 submitted to the journal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 08:39:32 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向： 头颈肿瘤 <br>经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的<span class="quote">风信子苗 2018-12-20 发表::<br>您好，做的什么研究</span><span class="quote">风信子苗 2018-12-20 00:00:00 发表:<br>您好，做的什么研究</span>, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究<span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 <span class="quote">Dr_Hemis_AI 2018-09-10 发表::<br>接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise</span><span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]
    2021-12-14 1465389cm38暂无昵称

    偏重的研究方向：头颈肿瘤
    经验分享：Dec 13 submitted to the journal

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1187022, encodeId=9de6118e0228d, content=Jan 21 2022 Under Review 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri Jan 21 23:19:00 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083439, encodeId=2a5f1083439a1, content=Dec 22 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Dec 23 07:47:28 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079991, encodeId=88db10e999113, content=Dec 14 with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 16:37:28 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079814, encodeId=a7aa10e98148d, content=偏重的研究方向：头颈肿瘤<br>经验分享：Dec 13 submitted to the journal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 08:39:32 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向： 头颈肿瘤 <br>经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的<span class="quote">风信子苗 2018-12-20 发表::<br>您好，做的什么研究</span><span class="quote">风信子苗 2018-12-20 00:00:00 发表:<br>您好，做的什么研究</span>, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究<span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 <span class="quote">Dr_Hemis_AI 2018-09-10 发表::<br>接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise</span><span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]
    2021-04-19 1465389cm38暂无昵称

    偏重的研究方向： 头颈肿瘤
    经验分享：Apr 18 变化一次时间

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1187022, encodeId=9de6118e0228d, content=Jan 21 2022 Under Review 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri Jan 21 23:19:00 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083439, encodeId=2a5f1083439a1, content=Dec 22 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Dec 23 07:47:28 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079991, encodeId=88db10e999113, content=Dec 14 with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 16:37:28 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079814, encodeId=a7aa10e98148d, content=偏重的研究方向：头颈肿瘤<br>经验分享：Dec 13 submitted to the journal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 08:39:32 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向： 头颈肿瘤 <br>经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的<span class="quote">风信子苗 2018-12-20 发表::<br>您好，做的什么研究</span><span class="quote">风信子苗 2018-12-20 00:00:00 发表:<br>您好，做的什么研究</span>, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究<span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 <span class="quote">Dr_Hemis_AI 2018-09-10 发表::<br>接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise</span><span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]
    2020-04-19 丫丫3036

    978372

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1187022, encodeId=9de6118e0228d, content=Jan 21 2022 Under Review 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri Jan 21 23:19:00 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083439, encodeId=2a5f1083439a1, content=Dec 22 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Dec 23 07:47:28 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079991, encodeId=88db10e999113, content=Dec 14 with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 16:37:28 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079814, encodeId=a7aa10e98148d, content=偏重的研究方向：头颈肿瘤<br>经验分享：Dec 13 submitted to the journal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 08:39:32 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向： 头颈肿瘤 <br>经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的<span class="quote">风信子苗 2018-12-20 发表::<br>您好，做的什么研究</span><span class="quote">风信子苗 2018-12-20 00:00:00 发表:<br>您好，做的什么研究</span>, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究<span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 <span class="quote">Dr_Hemis_AI 2018-09-10 发表::<br>接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise</span><span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]
    2019-12-03 1470cd80m57暂无昵称

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1187022, encodeId=9de6118e0228d, content=Jan 21 2022 Under Review 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri Jan 21 23:19:00 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083439, encodeId=2a5f1083439a1, content=Dec 22 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Dec 23 07:47:28 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079991, encodeId=88db10e999113, content=Dec 14 with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 16:37:28 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079814, encodeId=a7aa10e98148d, content=偏重的研究方向：头颈肿瘤<br>经验分享：Dec 13 submitted to the journal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 08:39:32 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向： 头颈肿瘤 <br>经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的<span class="quote">风信子苗 2018-12-20 发表::<br>您好，做的什么研究</span><span class="quote">风信子苗 2018-12-20 00:00:00 发表:<br>您好，做的什么研究</span>, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究<span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 <span class="quote">Dr_Hemis_AI 2018-09-10 发表::<br>接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise</span><span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]
    2019-01-09 Dr_Hemis_AI

    做头颈肿瘤分期的风信子苗 2018-12-20 发表::
    您好，做的什么研究    风信子苗 2018-12-20 00:00:00 发表:
    您好，做的什么研究

    风信子苗 2018-12-20 发表:: 您好，做的什么研究

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1187022, encodeId=9de6118e0228d, content=Jan 21 2022 Under Review 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri Jan 21 23:19:00 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083439, encodeId=2a5f1083439a1, content=Dec 22 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Dec 23 07:47:28 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079991, encodeId=88db10e999113, content=Dec 14 with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 16:37:28 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079814, encodeId=a7aa10e98148d, content=偏重的研究方向：头颈肿瘤<br>经验分享：Dec 13 submitted to the journal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 08:39:32 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向： 头颈肿瘤 <br>经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的<span class="quote">风信子苗 2018-12-20 发表::<br>您好，做的什么研究</span><span class="quote">风信子苗 2018-12-20 00:00:00 发表:<br>您好，做的什么研究</span>, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究<span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 <span class="quote">Dr_Hemis_AI 2018-09-10 发表::<br>接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise</span><span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]
    2018-12-20 风信子苗

    您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表:
    投了一篇， 1個月整有回覆 Revise

    Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1187022, encodeId=9de6118e0228d, content=Jan 21 2022 Under Review 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri Jan 21 23:19:00 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083439, encodeId=2a5f1083439a1, content=Dec 22 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Dec 23 07:47:28 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079991, encodeId=88db10e999113, content=Dec 14 with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 16:37:28 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079814, encodeId=a7aa10e98148d, content=偏重的研究方向：头颈肿瘤<br>经验分享：Dec 13 submitted to the journal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Dec 14 08:39:32 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向： 头颈肿瘤 <br>经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的<span class="quote">风信子苗 2018-12-20 发表::<br>您好，做的什么研究</span><span class="quote">风信子苗 2018-12-20 00:00:00 发表:<br>您好，做的什么研究</span>, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究<span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 <span class="quote">Dr_Hemis_AI 2018-09-10 发表::<br>接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise</span><span class="quote">Dr_Hemis_AI 2018-09-10 00:00:00 发表:<br>投了一篇， 1個月整有回覆 Revise</span>, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]
    2018-11-06 Dr_Hemis_AI

    一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表::
    接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise    Dr_Hemis_AI 2018-09-10 00:00:00 发表:
    投了一篇， 1個月整有回覆 Revise

    Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月 投了一篇， 1個月整有回覆 Revise

    0

共96条页码: 3/10页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分